Articles related to Exelixis

Exelixis says there is more to come after three stunning deals

August 31, 2009 - Conference: - Company:

CEO George Scangos and dealmaker Fran Heller
George Scangos, President and CEO of Exelixis, re-energized a troubled biotech industry, according to the Wall Street Journal, when he announced earlier this year he had licensed two cancer drugs to French pharmaceutical giant Sanofi-aventis with an upfront payment of USD 140 million.
The news came on the heels of Read more »

Newsletter

Subscribe to partneringNEWS
An online journal for executives in the life sciences, partneringNEWS™ is focused on the people behind the deals. Putting a human face to a collaboration agreement gives business development professionals the ability to get behind the headlines.

Sign up today to the free newsletter and never miss any new content.